رجوع
نطاق اليوم
KWD 3.94
KWD 4.11
نطاق 52 أسبوعًا
KWD 1.05
KWD 4.98
حجم التداول
583,128
متوسط 50 يوم / 200 يوم
KWD 3.98
/
KWD 3.66
الإغلاق السابق
KWD 3.86
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -3.6 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.8 |
| Net Margin % | -175.3 | 3.9 |
| Rev Growth 5Y % | 24.5 | 10.0 |
| D/E | — | 0.2 |
النقاط الرئيسية
Revenue grew 24.45% annually over 5 years — strong growth
Negative free cash flow of -141.44M
PEG of 0.10 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 9.60%
Capital efficient — spends only 0.32% of revenue on capex
النمو
Revenue Growth (5Y)
24.45%
Revenue (1Y)14.85%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
N/A
ROIC-32.11%
Net Margin-175.31%
Op. Margin-133.21%
الأمان
Debt / Equity
N/A
Current Ratio4.37
Interest Coverage-2.10
التقييم
P/E Ratio
-3.61
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14.85% | Revenue Growth (3Y) | 8.15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 24.45% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 81.36M | Net Income (TTM) | -142.62M |
| ROE | N/A | ROA | -44.14% |
| Gross Margin | 90.57% | Operating Margin | -133.21% |
| Net Margin | -175.31% | Free Cash Flow (TTM) | -141.44M |
| ROIC | -32.11% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4.37 |
| Interest Coverage | -2.10 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -3.61 | P/B Ratio | N/A |
| P/S Ratio | 6.32 | PEG Ratio | 0.10 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 514.53M | Enterprise Value | 692.20M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 81.36M | 70.84M | 69.56M | 209.91M | 33.92M |
| Net Income | -142.62M | -157.85M | -240.05M | -157.13M | -230.03M |
| EPS (Diluted) | -1.12 | -1.62 | -2.94 | -1.99 | -3.00 |
| Gross Profit | 73.68M | 64.89M | 67.03M | 206.61M | 32.52M |
| Operating Income | -108.38M | -130.65M | -165.99M | -123.34M | -261.72M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 323.15M | 321.98M | 354.78M | 490.86M | 617.97M |
| Total Liabilities | 508.98M | 524.62M | 503.03M | 411.41M | 451.88M |
| Shareholders' Equity | -185.83M | -202.64M | -148.25M | 79.45M | 166.09M |
| Total Debt | 439.01M | 123.00M | 124.38M | 129.85M | 139.70M |
| Cash & Equivalents | 261.34M | 250.87M | 278.60M | 326.44M | 466.54M |
| Current Assets | 306.34M | 307.39M | 336.29M | 434.98M | 525.18M |
| Current Liabilities | 70.16M | 80.47M | 67.67M | 81.94M | 73.94M |